|  |  |  | | | | Diseases | |  | Childhood Acute Lymphoblastic Leukaemia Trials |
| | |
| |  | Information Booklet |
A booklet produced by Leukaemia Research Fund giving background information on clinical trials is available to download.
Text version of the booklet
| Registers of Trials |
Current Controlled Trials
International Cancer Research Portfolio - a register of UK and US cancer research (including trials)
Last updated 02/10/2008
| Leukaemia Research sponsored trials |
European Intergroup Study on Post Induction Treatment of Philadelphia Positive Acute Lymphoblastic Leukaemia with Imatinib
(EsPhALL) | | Trial Code: | UKCRN ID 1425 | | Type: | II/III | | Status: | Open | | Link: | http://clinicaltrials.gov/show/NCT00287105 | | Website: | No website listed | | Leukaemia Research is funding the UK arm of this trial |
The Leukaemia Research Fund is funding the MRD-testing element of the UKALL2003 clinical trial.
See below for full details of this trial.
Last updated 02/10/2008
| Non-Leukaemia Research sponsored trials |
| United Kingdom Childhood Acute Lymphoblastic Leukaemia Randomised Trial 2003 (MRC UKALL 2003) | | Trial Code: | 07355119 | | Type: | Phase III | | Status: | Open | | Link: | http://www.controlled-trials.com/mrct/trial/120053... | | MRD High Risk group randomised to standard vs intensified therapy MRD Low Risk group randomised to standard vs reduced therapy |
| An International Collaborative Trial for Relapsed and Refractory Acute Lymphobalstic Leukaemia (UKALL R3) | | Trial Code: | 07355119 | | Type: | Phase III | | Status: | Open | | Link: | http://www.controlled-trials.com/ISRCTN45724312/Re... | | To examine the biology of relapsed Acute Lymphoblastic Leukaemia (ALL) and improve its outcome using a combination of chemotherapy and nationally standardised approach to Haematopoietic Stem Cell Transplantation (HSCT). |
| International collaborative treatment protocol for infants under one year with acute lymphoblastic leukaemia | | Type: | Phase III | | Status: | Ongoing | | Link: | http://www.controlled-trials.com/mrct/trial/CHILDH... | | To improve the outcome for infants (under the age of 1) with acute lymphoblastic leukaemia (ALL) - a group of children with a very poor prognosis who have not so far benefited from the advances in treatment seen in other childhood leukaemias. |
Last updated 02/10/2008 |
|
|
|
